KAEMPFEROL-3-O-ALPHA-L-RHAMNOPYRANOSYL-(1->6)-BETA-D-GALACTOPYRANOSIDE-7-O-ALPHA-L-ARABINOFURANOSIDE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | 8wkM8LUbKob |
|---|---|
| InChI | InChI=1S/C32H38O19/c1-10-19(36)23(40)26(43)30(46-10)45-9-17-21(38)24(41)27(44)32(50-17)51-29-22(39)18-14(35)6-13(47-31-25(42)20(37)16(8-33)49-31)7-15(18)48-28(29)11-2-4-12(34)5-3-11/h2-7,10,16-17,19-21,23-27,30-38,40-44H,8-9H2,1H3/t10-,16+,17+,19-,20+,21-,23+,24-,25-,26+,27+,30+,31-,32-/m0/s1 |
| InChIKey | PWFGPIVPLXWWQL-VDCLRNITSA-N |
| Mol Weight | 726.6 g/mol |
| Molecular Formula | C32H38O19 |
| Exact Mass | 726.200729 g/mol |
| Enantiomer InChIKey | PWFGPIVPLXWWQL-SCQRWXQVSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
KAEMPFEROL-3-O-RUTINOSIDE-7-O-GLUCOSIDE
KAEMPFEROL_3-O-BETA-[BETA-D-GLUCOPYRANOSYL-(1->6)-D-GLUCOPYRANOSIDE]-7-O-ALPHA-L-RHAMNOPYRANOSIDE
KAEMPFEROL-3-O-ALPHA-L-RHAMNOSYL-(1'''->6'')-O-BETA-D-GALACTOPYRANOSYL-7-O-BETA-D-APIOFURANOSIDE
KAEMPFEROL-3-O-ALPHA-ARABINOPYRANOSYL-(1'''-6'')-BETA-GLUCOPYRANOSIDE-7-O-BETA-GLUCOPYRANOSIDE
SACHALOSIDE-III;KAEMPFEROL-3-O-BETA-D-XYLOPYRANOSYL-(1->2)-BETA-D-GLUCOPYRANOSYL-7-O-ALPHA-L-RHAMNOPYRANOSIDE
KAEMPFEROL-3-(6''-ACETYL-BETA-GLUCOSIDE)-7-ALPHA-RHAMNOSIDE
KAEMPFEROL-3-O-BETA-D-GLUCOPYRANOSIDE-6''-(3-HYDROXY-3-METHYL-GLUTARATE)-7-O-BETA-D-GLUCOPYRANOSIDE
KAEMPFEROL-3-O-BETA-(6''-E-PARA-COUMAROYLGLUCOPYRANOSIDE)-7-O-BETA-GLUCOPYRANOSIDE
KAEMPFEROL-3-RUTINOSIDE-4'-GLUCOSIDE
KAEMPFEROL-3-O-[6''-SINAPOYL-GLUCOSIDE]-7-O-GLUCOSIDE
| Title | Journal or Book | Year |
|---|---|---|
| Two flavonol triglycosides from flowers of Indigofera hebepetala | Phytochemistry | 1996 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.